BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8319199)

  • 1. In vitro irradiation is able to cause RET oncogene rearrangement.
    Ito T; Seyama T; Iwamoto KS; Hayashi T; Mizuno T; Tsuyama N; Dohi K; Nakamura N; Akiyama M
    Cancer Res; 1993 Jul; 53(13):2940-3. PubMed ID: 8319199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
    Mizuno T; Iwamoto KS; Kyoizumi S; Nagamura H; Shinohara T; Koyama K; Seyama T; Hamatani K
    Oncogene; 2000 Jan; 19(3):438-43. PubMed ID: 10656692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.
    Klugbauer S; Pfeiffer P; Gassenhuber H; Beimfohr C; Rabes HM
    Genomics; 2001 Apr; 73(2):149-60. PubMed ID: 11318605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement].
    Rabes HM; Klugbauer S
    Verh Dtsch Ges Pathol; 1997; 81():139-44. PubMed ID: 9474864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
    Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
    Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG
    Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation.
    Caudill CM; Zhu Z; Ciampi R; Stringer JR; Nikiforov YE
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2364-9. PubMed ID: 15671095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
    Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
    Cancer Res; 1998 Jan; 58(2):198-203. PubMed ID: 9443391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement.
    Rabes HM; Klugbauer S
    Recent Results Cancer Res; 1998; 154():248-64. PubMed ID: 10027005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl.
    Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
    Oncogene; 1998 Feb; 16(5):671-5. PubMed ID: 9482114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident.
    Klugbauer S; Lengfelder E; Demidchik EP; Rabes HM
    Oncogene; 1995 Dec; 11(12):2459-67. PubMed ID: 8545102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
    Rabes HM; Demidchik EP; Sidorow JD; Lengfelder E; Beimfohr C; Hoelzel D; Klugbauer S
    Clin Cancer Res; 2000 Mar; 6(3):1093-103. PubMed ID: 10741739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer.
    Fugazzola L; Pierotti MA; Vigano E; Pacini F; Vorontsova TV; Bongarzone I
    Oncogene; 1996 Sep; 13(5):1093-7. PubMed ID: 8806699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.
    Hamatani K; Eguchi H; Ito R; Mukai M; Takahashi K; Taga M; Imai K; Cologne J; Soda M; Arihiro K; Fujihara M; Abe K; Hayashi T; Nakashima M; Sekine I; Yasui W; Hayashi Y; Nakachi K
    Cancer Res; 2008 Sep; 68(17):7176-82. PubMed ID: 18757433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors.
    Namba H; Yamashita S; Pei HC; Ishikawa N; Villadolid MC; Tominaga T; Kimura H; Tsuruta M; Yokoyama N; Izumi M
    Endocrinol Jpn; 1991 Dec; 38(6):627-32. PubMed ID: 1823030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
    Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
    Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.
    Salassidis K; Bruch J; Zitzelsberger H; Lengfelder E; Kellerer AM; Bauchinger M
    Cancer Res; 2000 Jun; 60(11):2786-9. PubMed ID: 10850414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation.
    Bounacer A; Wicker R; Schlumberger M; Sarasin A; Suárez HG
    Biochimie; 1997 Oct; 79(9-10):619-23. PubMed ID: 9466701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?
    Sugg SL; Zheng L; Rosen IB; Freeman JL; Ezzat S; Asa SL
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3360-5. PubMed ID: 8784097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
    Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
    Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.